SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Rich who wrote (559)2/22/1999 3:07:00 PM
From: Anthony Wong   of 942
 
Weekly Prescription Trends (22 February 1999):-

Diabetes: WLA's Rezulin new prescription market share decreased 10 basis points to 8.6% this week. Novo Nordisk/Schering-Plough's Prandin remained flat at 2.0% this week.

Cholesterol Lowering: WLA's Lipitor gained 40 basis points to 43.6% market share of new prescriptions. MRK's Zocor remained flat at 25.8% this week. Bristol's Pravachol lost 30 basis points to 16.5%.

askmerrill.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News